Reasonable Duration of Clopidogrel Use After Drug-Eluting Stent Implantation in Korean Patients

American Journal of Cardiology

Volumn 104, Issue 12, 2009, Pages 1668-1673

  Shin, Dong Ho ^a   Chae, In Ho ^b   Youn, Tae Jin ^b   Cho, Sung Il ^a   Kwon, Dong A ^b   Suh, Jung Won ^b   Chang, Hyuk Jae ^b   Cho, Young Seok ^b   Chung, Woo Young ^b   Choi, Young Jin ^c   Gwon, Hyeon Cheol ^d   Han, Kyoo Rok ^e   Choi, Dong Ju ^b  

^a Seoul National University   (South Korea)

^b Chungbuk National University College of Medicine   (South Korea)

^c Hallym University   (South Korea)

^d Sungkyunkwan University School of Medicine   (South Korea)

^e Hallym University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PACLITAXEL; RAPAMYCIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CLINICAL TRIAL; COHORT ANALYSIS; CONFIDENCE INTERVAL; DRUG ELUTING STENT; DRUG UTILIZATION; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; IMPLANTATION; KOREA; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RASH; STENT THROMBOSIS; TREATMENT DURATION;

AGED; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; FEMALE; HUMANS; KOREA; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; TICLOPIDINE; TIME FACTORS; TREATMENT OUTCOME;

EID: 70949090108     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.07.049     Document Type: Article

References (28)

1. Smith J.S.C., Feldman T.E., Hirshfeld J.J.W., Jacobs A.K., Kern M.J., King Iii S.B., Morrison D.A., O'Neill W.W., Schaff H.V., Whitlow P.L., Williams D.O., Antman E.M., Adams C.D., Anderson J.L., Faxon D.P., Fuster V., Halperin J.L., Hiratzka L.F., Hunt S.A., Nishimura R., Ornato J.P., Page R.L., and Riegel B. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). J Am Coll Cardiol 47 (2006) e1-e121
2. Kuchulakanti P.K., Chu W.W., Torguson R., Ohlmann P., Rha S.W., Clavijo L.C., Kim S.W., Bui A., Gevorkian N., Xue Z., Smith K., Fournadjieva J., Suddath W.O., Satler L.F., Pichard A.D., Kent K.M., and Waksman R. Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents. Circulation 113 (2006) 1108-1113
3. Pfisterer M., Brunner-La Rocca H.P., Buser P.T., Rickenbacher P., Hunziker P., Mueller C., Jeger R., Bader F., Osswald S., and Kaiser C. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol 48 (2006) 2584-2591
4. Lagerqvist B., James S.K., Stenestrand U., Lindback J., Nilsson T., and Wallentin L. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med 356 (2007) 1009-1019
5. Spaulding C., Daemen J., Boersma E., Cutlip D.E., and Serruys P.W. A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 356 (2007) 989-997
6. Kastrati A., Mehilli J., Pache J., Kaiser C., Valgimigli M., Kelbaek H., Menichelli M., Sabate M., Suttorp M.J., Baumgart D., Seyfarth M., Pfisterer M.E., and Schomig A. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 356 (2007) 1030-1039
7. Mauri L., Hsieh W.-H., Massaro J.M., Ho K.K.L., D'Agostino R., and Cutlip D.E. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 356 (2007) 1020-1029
8. Eshaghian S., Kaul S., Amin S., Shah P.K., and Diamond G.A. Role of clopidogrel in managing atherothrombotic cardiovascular disease. Ann Intern Med 146 (2007) 434-441
9. King III S.B., Smith Jr. S.C., Hirshfeld Jr. J.W., Jacobs A.K., Morrison D.A., and Williams D.O. 2007 focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention. J Am Coll Cardiol 51 (2008) 172-209
10. Eisenstein E.L., Anstrom K.J., Kong D.F., Shaw L.K., Tuttle R.H., Mark D.B., Kramer J.M., Harrington R.A., Matchar D.B., Kandzari D.E., Peterson E.D., Schulman K.A., and Califf R.M. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA 297 (2007) 159-168
11. Ho P.M., Fihn S.D., Wang L., Bryson C.L., Lowy E., Maynard C., Magid D.J., Peterson E.D., Jesse R.L., and Rumsfeld J.S. Clopidogrel and long-term outcomes after stent implantation for acute coronary syndrome. Am Heart J 154 (2007) 846-851
12. Brar S.S., Kim J., Brar S.K., Zadegan R., Ree M., Liu I.-L.A., Mansukhani P., Aharonian V., Hyett R., and Shen A.Y.-J. Long-term outcomes by clopidogrel duration and stent type in a diabetic population with de novo coronary artery lesions. J Am Coll Cardiol 51 (2008) 2220-2227
13. Serruys P.W., Ong A.T., van Herwerden L.A., Sousa J.E., Jatene A., Bonnier J.J., Schonberger J.P., Buller N., Bonser R., Disco C., Backx B., Hugenholtz P.G., Firth B.G., and Unger F. Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial. J Am Coll Cardiol 46 (2005) 575-581
14. Cutlip D.E., Windecker S., Mehran R., Boam A., Cohen D.J., van Es G.A., Steg P.G., Morel M.A., Mauri L., Vranckx P., McFadden E., Lansky A., Hamon M., Krucoff M.W., Serruys P.W., and Consortium AR. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 115 (2007) 2344-2351
15. Therneau T., Grambsch P., and Pankratz V. Penalized survival models and frailty. J Comput Graph Stat 12 (2003) 156-175
16. Braitman L.E., and Rosenbaum P.R. Rare outcomes, common treatments: analytic strategies using propensity scores. Ann Intern Med 137 (2002) 693-695
17. Cepeda M.S., Boston R., Farrar J.T., and Strom B.L. Comparison of logistic regression versus propensity score when the number of events is low and there are multiple confounders. Am J Epidemiol 158 (2003) 280-287
18. Kurth T., Walker A.M., Glynn R.J., Chan K.A., Gaziano J.M., Berger K., and Robins J.M. Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity-based weighting under conditions of nonuniform effect. Am J Epidemiol 163 (2006) 262-270
19. Steyerberg E.W., Eijkemans M.J., Harrell F.E., and Habbema J.D. Prognostic modeling with logistic regression analysis: in search of a sensible strategy in small data sets. Med Decis Making 21 (2001) 45-56
20. Cole S.R., and Hernan M.A. Constructing inverse probability weights for marginal structural models. Am J Epidemiol 168 (2008) 656-664
21. Cole S.R., and Hernán M.A. Adjusted survival curves with inverse probability weights. Comput Methods Programs Biomed 75 (2004) 45-49
22. Curtis L.H., Hammill B.G., Eisenstein E.L., Kramer J.M., and Anstrom K.J. Using inverse probability-weighted estimators in comparative effectiveness analyses with observational databases. Med Care 45 (2007) S103-S107
23. Sato T., and Matsuyama Y. Marginal structural models as a tool for standardization. Epidemiology 14 (2003) 680-686
24. Kimura T., Morimoto T., Nakagawa Y., Tamura T., Kadota K., Yasumoto H., Nishikawa H., Hiasa Y., Muramatsu T., Meguro T., Inoue N., Honda H., Hayashi Y., Miyazaki S., Oshima S., Honda T., Shiode N., Namura M., Sone T., Nobuyoshi M., Kita T., and Mitsudo K. J-Cypher Investigators Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation. Circulation 119 (2009) 987-995
25. The Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 345 (2001) 494-502
26. Bhatt D.L., Fox K.A.A., Hacke W., Berger P.B., Black H.R., Boden W.E., Cacoub P., Cohen E.A., Creager M.A., Easton J.D., Flather M.D., Haffner S.M., Hamm C.W., Hankey G.J., Johnston S.C., Mak K.-H., Mas J.-L., Montalescot G., Pearson T.A., Steg P.G., Steinhubl S.R., Weber M.A., Brennan D.M., Fabry-Ribaudo L., Booth J., Topol E.J., and CHARISMA Investigators. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 354 (2006) 1706-1717
27. Diez Roux A.V., Merkin S.S., Arnett D., Chambless L., Massing M., Nieto F.J., Sorlie P., Szklo M., Tyroler H.A., and Watson R.L. Neighborhood of residence and incidence of coronary heart disease. N Engl J Med 345 (2001) 99-106
28. Shishehbor M.H., Litaker D., Pothier C.E., and Lauer M.S. Association of socioeconomic status with functional capacity, heart rate recovery, and all-cause mortality. JAMA 295 (2006) 784-792